AbbVie Inc. is 248.1x more valuable than Nuvation Bio Inc. by market capitalization ($399.47 B vs $1.61 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NUVB | ABBV |
|---|---|---|
| Market cap | $1.61 B | $399.47 B |
| US-listed rank | #2262 | #28 |
| Revenue (latest FY) | $62.90M | $61.16B |
| Net income (latest FY) | -$204.63M | $4.23B |
| Net margin | -325.3% | 6.9% |
| P/E (trailing FY) | - | 94.5 |
| SEC filings | 379 | 1,008 |
AbbVie Inc. is 248.1x more valuable than Nuvation Bio Inc. by market capitalization ($399.47 B vs $1.61 B).
In their latest fiscal years, Nuvation Bio Inc. reported $62.90M in revenue while AbbVie Inc. reported $61.16B.
Full pages: Nuvation Bio Inc. and AbbVie Inc., or browse the full rankings.